Skip to content

MetLife

US · MET #367 by market cap Listed 2000
95.67 -1.93 -1.98%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 98.26 +0.68%
After-hours 96.29 +0.65%
Overnight 97.60 0.00%
103.5780.4695.672026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MET?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +17.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 1.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 14:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 12.5x Better than 68%
Forward P/E 10.1x Better than 80%
Price / Sales 0.8x Better than 83%
P/E vs own 5-yr range 29th pctl Better than 78%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 3.9% Better than 42%
Net income CAGR (3Y) -13.8% Better than 23%
Free cash flow CAGR (3Y) 9.4% Better than 52%
Profitability B-

How much profit the business keeps from each dollar of sales and capital.

Net margin 4.2% Better than 41%
Return on equity 11.4% Better than 57%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 1.4% Better than 77%
6-month return 14.5% Better than 77%
12-month return (ex latest month) 34.4% Better than 73%
Distance below 52-week high 10.4% Better than 82%
Financial Health A

Balance-sheet strength: leverage, liquidity and interest coverage.

Debt to assets 2.7% Better than 85%
Interest coverage 5.4x Better than 58%
Free cash flow / net income 505.8% Better than 93%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 91.7% Better than 75%
Upside to average target 19.7% Better than 32%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.80%
1M -5.45%
3M +2.36%
6M +16.67%
YTD +23.76%
1Y +32.16%
3Y +65.82%
5Y +80.49%

Key statistics

Price & volume

Prev close
97.60
Open
97.88
Day range
95.22 - 99.39
Avg price
96.72
Volume
4.31M
Turnover
416.89M
Amplitude
4.27%
52-week range
66.02 - 106.72

Valuation

P/E
20.31
P/E (TTM)
12.51
P/B
2.71
EPS
4.71
Net profit
2.96B
Net assets
22.23B

Share structure

Market cap
60.12B
Float cap
50.29B
Shares out
628.44M
Float shares
525.71M

Dividend & listing

Dividend (TTM)
2.32
Listing date
2000-04-05
52-week range 73% of range
66.02 106.72

10.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-1.87M net over the window

Short interest

Shares short
10.75M
As of
2026-10-30

Frequently asked questions

What is the current stock price of MetLife (MET)?

MetLife last traded at 95.67. This page shows a periodic quote snapshot. Check the displayed quote time.

What is MetLife's market cap?

About 60.12B.

What is the P/E ratio of MetLife?

The trailing twelve-month P/E is 12.51, below its own 5-year average of 17.05 — toward the bottom of its historical range (28.69% percentile). See the Valuation tab for the full history.

Does MetLife pay a dividend?

Yes. The trailing dividend yield is 2.43%. The 2025 payout was up 4.3% from 2024. See the Dividends tab for the full payment history.

Is MetLife a buy according to analysts?

The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 114.55, which implies 19.7% upside from the current price. This is not investment advice.

What is MetLife's StockVane Quant Rating?

The StockVane Momentum strategy currently rates MetLife a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

MetLife discussion 0 comments

Add a comment